Cancer cell simulation platform raises Series A funding
The company behind a cancer cell simulation platform has raised 拢17.3 million Series A financing to advance programmes and partnerships towards the clinic. Based in London with offices in Cambridge and Budapest, Hungary, Turbine鈥檚 trademarked Simulated Cell platform identifies novel cancer treatments and high unmet need patient groups.It says this allows it to target its … Continue reading Cancer cell simulation platform raises Series A funding
